Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Nanomedicine. 2021 Sep 13;39:102459. doi: 10.1016/j.nano.2021.102459

Table 3.

IC50 values of the various PTX-NFGs in breast cancer cell lines.

Treatment IC50 (ng/mL)a
MCF-7 LCC-6-WT LCC-6-MDR
PTX 4.2 ± 2.7 6.6 ± 2.1 217 ± 76
PTX-NFG/A 9.2 ± 2.8 7.5 ± 1.1 102 ± 14**
PTX-NFG/B 4.7 ± 1.9 6.2 ± 2.2 399 ± 202
PTX-NFG/C 5.2 ± 4.4 15.8 ± 2.7 245 ± 50
PTX-NFG/D 8.1 ± 7.7 4.2 ± 0.3 63 ± 22**
PTX-NFG/E 2.0 ± 1.5 5.3 ± 1.1 89 ± 37**
PTX-NFG/F 5.8 ± 1.3 1.7 ± 0.8 243 ± 24
a

Data represent mean ± S.D. (n=6).

**

P<0.01 compared to free PTX.